AN IN-SILICO APPROACH TO REPURPOSE FDA-APPROVED PROPRANOLOL AGAINST PD-L1 PROTEIN TARGET IN CANCER TREATMENT /
Uloženo v:
| Hlavní autor: | |
|---|---|
| Korporativní autor: | |
| Médium: | Kniha |
| Jazyk: | angličtina |
| Vydáno: |
Dhaka :
BME DEPT. MIST,
c2026.
|
| Témata: | |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
Podobné jednotky: AN IN-SILICO APPROACH TO REPURPOSE FDA-APPROVED PROPRANOLOL AGAINST PD-L1 PROTEIN TARGET IN CANCER TREATMENT /
- IDENTIFICATION OF ANTICANCER DRUG THROUGH STUDYING THE ACTIVATION MECHANISM OF CASPASE PROTEIN: AN IN SILICO APPROACH
- IDENTICATION OF ANTICANCER DRUG THROUGH STUDYING THE ACTIVATION MECHANISM OF CASPASE PROTEIN: AN IN SILICO APPROACH /
- Inside the FDA : the business and politics behind the drugs we take and the food we eat /
- AN INTEGRATED TRANSCRIPTOMIC APPROACH TO IMMUNE PROFILING, HUB GENE DETECTION, AND IDENTIFICATION OF REPURPOSABLE DRUGS IN PANCREATIC CANCER /
- AN IN-SILICO APPROACH TO COMPARE MUTANT E PROTEIN STRUCTURE BETWEEN OLD AND RECENT DENGUE VIRUS EPISODES /
- ART AGAINST GENOCIDE /